cdc-rfa-dp16-01602publication.pdf

Centers for Disease Control and Prevention

National Center for Chronic Disease Prevention and Health Promotion

Improving Epilepsy Programs, Services, and Outcomes through National Partnerships

CDC-RFA-DP16-1602

Application Due Date: 04/07/2016

Signature Date

Improving Epilepsy Programs, Services, and Outcomes through National Partnerships

CDC-RFA-DP16-1602

TABLE OF CONTENTS

Part I. Overview Information Federal Agency NameA.

Funding Opportunity TitleB.

Announcement TypeC.

Agency Funding Opportunity NumberD.

Catalog of Federal Domestic Assistance (CFDA) NumberE.

Dates F.

Executive Summary G.

Part II. Full Text Funding Opportunity Description A.

Award Information B.

Eligibility Information C.

Application and Submission Information D.

Review and Selection Process E.

Award Administration Information F.

Agency Contacts G.

Other Information H.

Glossary I.

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-DP16-1602. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry

(ATSDR)

B. Funding Opportunity Title:

Improving Epilepsy Programs, Services, and Outcomes through National Partnerships C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered Research for this purpose is defined at http://www.cdc. gov/od/ science/ integrity/ docs/cdc- policy- distinguishing- public- health- research- nonresearch. pdf.

D. Agency Funding Opportunity Number:

CDC-RFA-DP16-1602

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.850 F. Dates:

1. Due Date for Letter of Intent (LOI): 01/29/2016

2. Due Date for Applications: 04/07/2016, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Date for Informational Conference Call:

Informational call will be held on Tuesday, February 2, 2016 at 2pm Eastern time.

Call in number: 855-644-0229 (Toll Free). Use passcode 6966716.

G. Executive Summary:

1. Summary Paragraph:

This Funding Opportunity Announcement is designed to improve health and quality of life for people with epilepsy. This funding will support actions related to three core public health functions applied to epilepsy:

developing workforce competency, mobilizing community partnerships and actions, and educating and empowering people about epilepsy. These complementary activities will aim to:

Reduce the treatment gap (i.e., shorten the time to diagnosis, and increase referrals to specialty care) by improving professional education about epilepsy diagnosis, treatment, and management;

Increase access to appropriate health care services, community resources, and self-management supports;

Improve the public’s knowledge about, and attitudes toward, epilepsy to reduce epilepsy stigma; and Improve health, social participation, and quality of life for people with epilepsy.

a. Eligible Applicants: Open Competition https://foa.grantsolutions.gov/announcementmodule/www.grants.gov https://foa.grantsolutions.gov/announcementmodule/www.grants.gov http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.grants.gov

b. FOA Type: Cooperative Agreement

c. Approximate Number of Awards: 2 Expected number of awards is 1-2. Subject to the availability of funding, including direct and indirect costs.

d. Total Project Period Funding: $16,000,000

e. Average One Year Award Amount: $3,200,000 If one award, the approximate award will be $3,200,000. If 2 awards, this amount will be shared between 2 awardees; approximate average award will be $1,600,000.

Subject to the availability of funding, including direct and indirect costs.

f. Total Project Period Length: 5

g. Estimated Award Date: 09/30/2016

h. Cost Sharing and / or Matching Requirements:

N

Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this FOA exists, leveraging other resources and promoting program sustainability are strongly encouraged.

Part II. Full Text A. Funding Opportunity Description

1. Background

a. Overview This Funding Opportunity announcement is designed to improve health and quality of life for people with epilepsy. Epilepsy is a chronic neurological condition characterized by recurrent seizures that can be caused by many different conditions that affect a person’s brain. In the U.S., about 2.9 million people have active epilepsy (that is, physician-diagnosed epilepsy either currently under treatment or accompanied by ≥1 seizure in the past year). People with epilepsy are likely to have multiple chronic conditions, live in households at lowest income levels, and are significantly more likely to report being disabled and having impaired health-related quality of life. Epilepsy results in an estimated annual cost of $15.5 billion in medical costs and lost or reduced earnings and productivity.

CDC's analysis of 2010 and 2013 data from the National Health Interview Survey (NHIS) found that about 58% of adults with active epilepsy reported having one or more seizures in the past year, and of these, 38% had not seen a neurologist or epilepsy specialist in the past year. These findings suggest that many people are not receiving the best care for this complex condition. Delayed recognition of seizures and inadequate treatment increase a person’s risk of subsequent seizures, brain damage, other injuries, disability, and early death.

Although epilepsy is widely recognized by the public, it is poorly understood, even among people who know someone with the disorder. While negative stereotypes about epilepsy have decreased over past decades, CDC studies have found that the public continues to be unfamiliar with appropriate seizure first-aid, and report perceived risk and safety concerns regarding being around a person with epilepsy. Public misunderstanding and stigma marginalize people with epilepsy, limiting their life opportunities and social participation.

In 2012, the Institute of Medicine released Epilepsy across the Spectrum: Promoting Health and Understand ing. This report describes the current gaps, challenges, and opportunities for public health to address epilepsy, and suggests 13 recommendations for action. CDC can play a key role in 12 of these, including http://iom.nationalacademies.org/Reports/2012/Epilepsy-Across-the-Spectrum.aspx http://iom.nationalacademies.org/Reports/2012/Epilepsy-Across-the-Spectrum.aspx improving health professionals’ education about epilepsy, improving the delivery and coordination of community services, informing media to improve awareness and eliminate stigma, and improving and expanding educational opportunities for people with epilepsy and their families.

Based upon the CDC Epilepsy Program’s goals, previous grant accomplishments, the IOM recommendations on epilepsy, and the input of more than a dozen stakeholder groups, this new Funding Opportunity Announcement will support three core public health functions applied to epilepsy: workforce competency, mobilizing community partnerships and actions, and educating and empowering people about epilepsy.

b. Statutory Authorities This program is authorized under the Public Health Service Act § 301(a) and 317(k)(2), 42 U.S.C. § 241(a) and 247b(k)(2), as amended.

c. Healthy People 2020 This FOA addresses the following Healthy People 2020 Focus Areas:

1. Disability and Health

DH-6: Increase the proportion of people with epilepsy and uncontrolled seizures who receive appropriate medical care.

DH-9: Reduce the proportion of people with disabilities who encounter barriers to participating in home, school, work, or community activities.

DH-17: Increase the proportion of adults with disabilities who report sufficient social and emotional support.

DH-18 (developmental): Reduce the proportion of people with disabilities who report serious psychological distress.

2. Health-Related Quality of Life and Well Being ;

HRQOL/WB-1.1: Increase the proportion of adults who self-report good or better health.

d. Other National Public Health Priorities and Strategies CDC/National Center for Chronic Disease Prevention and Health Promotion, Four Domains of Chron ic Disease Prevention: Environmental Approaches, Community Programs Linked to Clinical Services.

National Prevention Strategy focus areas: Clinical and Community Preventive Services, Empowered People, and Eliminate Health Disparities.

HHS Initiative on Multiple Chronic Conditions goals: Empowering the individual to use self-care management; Equipping health care providers with tools, information, and other interventions.

e. Relevant Work This FOA builds upon work completed under CDC-RFA-DP11-1104, Development and Implementation of Programs to Enhance Epilepsy Public Awareness, Knowledge and Partnership. More information about the CDC Epilepsy Program and related work may be found at www.cdc.gov/epilepsy .

2. CDC Project Description

a. Approach http://www.healthypeople.gov/2020/topics-objectives/topic/disability-and-health http://www.healthypeople.gov/2020/topics-objectives/topic/health-related-quality-of-life-well-being http://www.cdc.gov/chronicdisease/pdf/four-domains-factsheet-2015.pdf http://www.cdc.gov/chronicdisease/pdf/four-domains-factsheet-2015.pdf http://www.surgeongeneral.gov/priorities/prevention/strategy/ http://www.hhs.gov/ash/initiatives/mcc/ http://www.cdc.gov/epilepsy

Bold indicates project period outcome.

CDC-RFA-DP16-1602 Logic Model: Improving Epilepsy Programs, Services, and Outcomes through National Partnerships was developed to outline the activities and expected outcomes of this effort. This logic model depicts the strategies/activities and short-term, intermediate, and long-term outcomes in order to illustrate how the FOA strives to achieve its overarching goal.

Strategies & Activities Short Term Outcomes Intermediate Outcomes Long Term Outcomes

Assure a Competent Workforce

Implement, disseminate, and evaluate epilepsy training materials for various health professionals

Increased number of professional organizations adopting and disseminating epilepsy training material Increased knowledge among health care professionals regarding:

Effective diagnosis, treatment, and management of epilepsy and its comorbidities Cultural, health literacy, and psychosocial factors that impact epilepsy care

Increased number of PWE who get appropriate and timely medical care Improved social participation (e.g., employment, school attendance) among PWE Decreased public stigma

Improved health and quality of life among

PWE

Mobilize Community Partnerships to Improve the Delivery and Coordination of Epilepsy Care

Develop, implement, evaluate, disseminate, and provide technical assistance for evidence-based or promising approaches to improve time to diagnosis, referrals to specialty care, and access to self-management supports

Increased number of communities advancing care and support for epilepsy via health systems or health transformation opportunities Increased availability of local community resources that assist people with epilepsy Increased number of people with epilepsy using evidence-based self-management and wellness programs and supports

Inform, Educate, and Empower People

Conduct and evaluate broad public awareness campaigns Implement and evaluate educational programs for specific groups Educate people with epilepsy and their caregivers

Increased general public knowledge about epilepsy Increased knowledge among specific, selected audiences

BOLD indicates outcomes to be achieved by the awardee during the 5-year project period.

PWE = People with epilepsy

i. Purpose This FOA supports three core public health functions applied to epilepsy: developing workforce competency, mobilizing community partnerships and actions, and educating and empowering people about epilepsy. These complementary activities will aim to:

Reduce the treatment gap (i.e., shorten the time to diagnosis, and increase referral to specialty care) by improving professional education about epilepsy diagnosis, treatment, and management;

Increase access to appropriate health care services, community resources, and self-management supports;

Improve the public’s knowledge about, and attitudes toward, epilepsy to reduce epilepsy stigma; and Improve health, social participation, and quality of life for people with epilepsy.

ii. Outcomes As presented in the logic model, this project is expected to make a contribution toward the long term outcome of improving health and quality of life among people with epilepsy (PWE). During the 5 year project period, the awardee will be expected to show progress on both the Short Term and Intermediate Outcomes outlined in the model and below.

Short Term Outcomes

1. Assure a Competent Workforce

Increased number of professional organizations adopting and disseminating epilepsy training materials.

Increased knowledge among health care professionals regarding:

Effective diagnosis, treatment, and management of epilepsy and its comorbidities.

Cultural, health literacy, and psychosocial factors that impact epilepsy care.

2. Mobilize Community Partnerships to Improve the Delivery and Coordination of Epilepsy Care

Increased number of communities advancing care and support for epilepsy via health systems or health transformation opportunities.

Increased availability of local community resources that assist people with epilepsy.

Increased number of people with epilepsy using evidence-based self-management and wellness programs and supports. (See Glossary for definition).

3. Inform, Educate, and Empower People

Increased general public knowledge about epilepsy.

Increased knowledge among specific, selected audiences.

Intermediate Outcomes

Increased number of people with epilepsy who get appropriate and timely medical care.

Improved social participation (e.g., employment, school attendance) among people with epilepsy.

Decrease public stigma.

iii. Strategies and Activities The Strategies and Activities described in the logic model and below align with three of the ten essential public health services and with two domains within CDC’s Four Domains of Chronic Disease Prevention (Environmental Approaches and Community Programs Linked to Clinical Services).

The recommended Strategies and Activities of this FOA include:

1. Assure a Competent Workforce

Implement, disseminate, and evaluate epilepsy training materials for various health professionals.

2. Mobilize Community Partnerships to Improve the Delivery and Coordination of Epilepsy Care

Develop, implement, evaluate, disseminate, and provide technical assistance for evidence-based (See Glossary for definition) or promising approaches to improve time to diagnosis, referrals to specialty care, and access to self-management supports.

3. Inform, Educate, and Empower People

Conduct and evaluate broad public awareness campaigns.

Implement and evaluate educational programs for specific groups.

Educate people with epilepsy and their caregivers.

The applicant may propose additional strategies and activities in order to achieve the expected outcomes.

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

CDC expects the awardee to work with other CDC-funded programs in order to expand the availability of proven interventions and well-tested epilepsy education materials. For example, the awardee will use evidence-based programs and materials from the CDC Prevention Research Centers in order to address culturally diverse groups, literacy levels, self-management, and continuing education and training for health care providers and others providing services and support.

The CDC Epilepsy Program also encourages collaborations with other CDC programs that will enhance the dissemination and uptake of programs funded under this cooperative agreement, such as with the CDC School Health ;Program or Healthy Aging Program.

b. With organizations not funded by CDC:

Applicants are strongly encouraged to collaborate with the following stakeholders in order to address the requirements of this FOA:

People with epilepsy and their caregivers State and local public health agencies State and local aging agencies Mental health agencies and organizations http://www.cdc.gov/nceh/ehs/ephli/core_ess.htm http://www.cdc.gov/nceh/ehs/ephli/core_ess.htm http://www.cdc.gov/chronicdisease/pdf/four-domains-factsheet-2015.pdf http://www.cdc.gov/prc http://www.cdc.gov/healthyyouth/schoolhealth/ http://www.cdc.gov/healthyyouth/schoolhealth/ http://www.cdc.gov/aging/index.html

National- and state-based professional organizations (e.g. those reaching primary care providers, neurologists, school nurses, law enforcement, etc.)

State- and local-based organizations with expertise in/access to specific populations (e.g. older adults, students, racially and ethnically diverse groups, people in the workforce, etc.)

The Epilepsy Leadership Council HHS Workgroup on Epilepsy The Institute of Medicine

Applicants are required to include letters of support, MOUs, and/or MOAs from partners who will be involved in the activities proposed for this FOA.

2. Target Populations The target populations will vary depending on the particular Strategies and Activities being addressed.

1. Assure a Competent Workforce: Health care providers (e.g. physicians, nurses, community health workers, and other providers who treat or provide other preventive services or professional support to people with epilepsy in family/general practice, internal medicine, pediatrics, and neurology settings).

2. Mobilize Community Partnerships to Improve the Delivery and Coordination of Epilepsy Care: Health and social service agencies, health systems, and community coalitions or community groups who can support people with epilepsy and their caregivers.

3. Inform, Educate, and Empower People: People with epilepsy and their caregivers, general public, specific groups that may serve people with epilepsy (e.g. older adult service organizations, schools, employers, law enforcement).

Applicants are required to identify and describe the specific target population or populations for each activity.

a. Inclusion Where applicable, applicants are required to describe how they are reaching racially or ethnically diverse populations, older adults, non-English speaking populations, people with limited health literacy, geographically defined populations, people with limited access to health care, or those with low socioeconomic status.

iv. Funding Strategy N/A

b. Evaluation and Performance Measurement The CDC strategy for monitoring and evaluating program and awardee performance will use both process and outcome evaluations, and will be consistent with the logic model presented earlier. These evaluation questions and performance measures will yield information regarding program impact on target populations.

Evaluation findings will be used to inform programmatic planning and to guide technical assistance CDC will provide to the awardee.

Working with the awardee, CDC will monitor the following potential performance measures annually (subject to modification during the first six months of the project period):

Short-term Outcomes Potential Process Performance Measures

1. Did the awardee take steps to assure a competent workforce?

Increased number of professional organizations adopting and disseminating epilepsy training materials Increased knowledge among health care professionals regarding:

Effective diagnosis, treatment, and management of epilepsy and its comorbidities Cultural, health literacy, and psychosocial factors that impact epilepsy care

Baseline measures (in selected areas/geographic locations):

# and type of training materials available # and type of trainings available Health care provider knowledge regarding:

Diagnosis, treatment, and management of epilepsy Cultural, health literacy, and psychosocial factors

Grant period measures (in selected areas/geographic locations):

# and type of training materials developed or updated # and type of trainings delivered % of participants who completed all training components % of all potential participants reached # of professional organizations adopting and/or maintaining dissemination of epilepsy training material/programs Changes in health care provider knowledge from baseline

2. Did the awardee mobilize community partnerships to improve the delivery and coordination of epilepsy care?

Increased number of communities advancing care and support for epilepsy via health systems or health transformation opportunities Increased availability of local community resources that assist people with epilepsy Increased number of people with epilepsy using evidence-based self-management and wellness programs and supports (See Glossary for definition)

# of communities engaged in improving healthcare models that serve people with epilepsy # and type of organizations, agencies, and/or providers in communities providing coordinated epilepsy care # and type of current community resources for people with epilepsy % of people with epilepsy using various types of evidence-based self-management and wellness programs # of clinics working to link clinical services to the community (this will include both provision of payment and connections with local supports)

Grant period measures (in selected

# of new communities engaged in improving healthcare models that serve people with epilepsy # of new clinics working to link clinical services to the community % of providers/clinics referring people with epilepsy to self-management support # and type of new or expanded community resource # and type of new or expanded evidence-based self-management or wellness programs made available % of people with epilepsy referred to such programs % of people with epilepsy who are participating in such programs

3. Did the awardee inform, educate, and empower people?

Increased general public knowledge about epilepsy Increased knowledge among specific, selected audiences

Baseline measures (in selected populations, geographic areas of focus):

General public knowledge, attitudes, and practices related to epilepsy Knowledge, attitudes, and practices related to epilepsy # training programs targeting selected groups (e.g. older adult caregivers, schools, law enforcement, etc.)

Demographic characteristics Level of confidence in managing personal health and wellness among people with epilepsy

Grant period measures: (in selected populations, geographic areas of focus)

# of new messages about epilepsy developed and disseminated # and type of campaigns % of target population reached # and type of new training programs developed targeting selected groups (e.g.

older adult caregivers, schools, law enforcement, etc.)

# and type of training programs implemented targeting selected groups (e.g. older adult caregivers, schools, law enforcement, etc.)

# and proportion of program participants from selected target groups (e.g. older adult caregivers, schools, law enforcement, etc.)

Changes in knowledge, attitudes, and practices among the general public

Changes in levels of confidence in managing personal health and wellness among people with epilepsy Changes in knowledge, attitudes, and practices among program participants

Intermediate Outcomes Potential Outcome Performance Measures

Increased number of people with epilepsy who get appropriate and timely medical care Improved social participation (e.g., employment, school attendance) among people with epilepsy Decreased public stigma

% of people with epilepsy getting appropriate and timely medical care Levels of social participation among people with epilepsy Attitudes towards people with epilepsy Perceived stigma among people with epilepsy

Grant period measures (in selected

% of people with epilepsy being referred to appropriate care % of people with epilepsy accessing appropriate care % of people with epilepsy participating in various social activities Changes in attitudes towards people with epilepsy Changes in perception of stigma among people with epilepsy

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this FOA. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant).

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan within the first 6 months of award, as described in the Reporting Section of this FOA.

Applicants must provide an initial evaluation and performance measurement plan in their application that describes how they will show progress in implementing program strategies and activities, and in achieving program outcomes. This measurement plan must be consistent with the CDC evaluation and performance measurement strategies mentioned above. The plan must describe the monitoring and evaluation process, including indicators, process measures, analysis, and reporting to be used to track and measure progress in meeting program objectives and to document the reach of strategies. The applicant must describe how the results will be reported and used to enhance progress and performance. The applicant must identify and designate staff who will oversee the evaluation design, process and implementation. The plan should also address facilitators and barriers to achieving progress on the measures.

The applicant evaluation and performance measurement plan will comprise, but not be limited to, the following components:

General description of the evaluation, including a logic model;

Identification of individuals responsible for planning and implementing the evaluation;

Tracking of progress and completion of project activities and strategies;

Description of indicators for process and outcome measures (i.e., Awardee will work with CDC post award to set targets and monitor progress towards these targets);

Description of how evaluation results will be used for program improvement;

Description of how key partners will be engaged in the evaluation and performance measurement process; and Description of potentially available data sources and feasibility of collecting appropriate evaluation and performance data.

The awardee is expected to work with the CDC program and use grant funds to hire an experienced evaluator in order to address all of these components. During the first six months of the project period, CDC and the awardee will finalize the Evaluation and Performance Plan.

c. Organizational Capacity of Awardees to Implement the Approach Organizational capacity ensures that applicants demonstrate their ability to successfully execute the FOA strategies and meet project outcomes. Applicants should have adequate infrastructure, including:

Serving as an organization with documented experience serving the needs of people with epilepsy with a national legally affiliated network (legal authority to conduct work under the name of the national organization), accountable under a series of approved criteria and standards with robust quality assurance. In order for this program to have nationwide impact, the organization should be able to disseminate strategies to at least 25 states.

Ability to work with the public health workforce at national, state, and local levels.

Ability to demonstrate a history of results and effectiveness in the topic areas included in this FOA.

Ability to establish and maintain strong working relationships with stakeholders (e.g. people with epilepsy, health care providers, and subject matter experts) to inform and implement programmatic initiatives.

Ability to plan, implement, monitor, and evaluate programs.

Ability to manage programs and resources ensuring the administrative, financial, and staff support necessary to sustain activities, distribute funding to subcontractors/grantees in a timely manner, and hire or contract with skilled personnel.

Ability to effectively gather, analyze, interpret, and use evidence-based or evidence-informed

Ability to effectively gather, analyze, interpret, and use evidence-based or evidence-informed strategies where such information exists.

Applicants are expected to describe their experience supporting public health programs in epilepsy and briefly document their history serving or working with the target populations identified in this FOA. This includes documenting any outcomes or benefits that were demonstrated as a result.

d. Work Plan The applicant is required to provide a high-level work plan in narrative form that covers the duration of the five-year project. Additionally, the applicant must provide a detailed work plan for the first year of the project period. The work plan must align with the activities and strategies outlined in this FOA.

The detailed work plan must include, at a minimum:

A description of activities, staff person responsible, associated timelines, target population, performance measures/milestones that align with FOA outcomes and the FOA logic model.

Objectives written in SMART (specific, measurable, achievable, realistic, and time-phased) format.

Quantitative baselines should be provided for each objective that seeks to increase, decrease, or maintain a certain number over time.

A description of staff and administrative roles and functions to support implementation of the award.

Specify management and leadership positions and qualifications for those roles.

Administrative and assessment processes to ensure successful implementation and quality assurance.

CDC will provide feedback and technical assistance to the awardee to finalize the work plan post-award. A sample work plan format is presented below.

Expected Outcome 1:

Activity Target Population

Performance Measure

Data Source Person Responsible

Timeframe

1.

2.

Expected Outcome 2:

Activity Target Population

Performance Measure

Data Source Person Responsible

Timeframe

1.

2.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and awardees, site visits, and awardee reporting (including work plans, performance, and financial reporting). Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking awardee progress in achieving the desired outcomes.

Ensuring the adequacy of awardee systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that awardees are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with awardees on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Other activities deemed necessary to monitor the award, if applicable.

These activities may include monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk grantees.

CDC will work with the awardee to set up monthly calls with the CDC Project Officer and any relevant awardee staff to ensure regular monitoring, and so that technical assitance can be provided.

f. CDC Program Support to Awardees (THIS SECTION APPLIES ONLY TO COOPERATIVE

AGREEMENTS)

In a cooperative agreement, CDC staff is substantially involved in the program activities, above and beyond routine grant monitoring.

1. Technical Assistance:

Conduct a pre-award technical assistance call to answer questions for potential applicants.

Provide post award technical assistance, including:

Guidance to improve the quality and effectiveness of work plans, evaluation strategies, products and services, and collaborative activities with other organizations;

Collaborate to develop the most relevant communication messages;

Collaborate in the planning, implementation, and evaluation of meetings related to work conducted under this FOA; and Provide resources and tools necessary for the successful implementation of strategies and activities to meet project goals.

2. Information sharing:

Facilitate routine conference calls, webinars, and information exchange among awardees and epilepsy and public health stakeholders; and Collaborate to compile and publish accomplishments, best practices, and lessons learned during the project period.

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the

CDC Program Support to Awardees Section.

2. Award Mechanism: U58

3. Fiscal Year: 2016

4. Approximate Total Fiscal Year Funding: $3,200,000

5. Approximate Project Period Funding: $16,000,000

This amount is subject to the availability of funds.

Estimated Total Funding: $3,200,000

6. Total Project Period Length: 5 year(s)

7. Expected Number of Awards: 2 Expected number of awards is 1-2. Subject to the availability of funding, including direct and indirect costs.

8. Approximate Average Award: $3,200,000 Per Budget Period If one award, the approximate award will be $3,200,000. If 2 awards, this amount will be shared between 2 awardees; approximate average award will be $1,600,000.

Subject to the availability of funding, including direct and indirect costs.

9. Award Ceiling: $4,000,000 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor: None

11. Estimated Award Date: 09/30/2016

12. Budget Period Length: 12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the awardee (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Additional Eligibility Category:

2. Additional Information on Eligibility

3. Justification for Less than Maximum Competition N/A

4. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this FOA exists, leveraging other resources and promoting program sustainability are strongly encouraged.

5. Maintenance of Effort Maintenance of effort is not required for this program.

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC.

If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the “Get Registered” option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up 1 Data Universal

Number System

(DUNS)

1. Click on http:// fedgov.dnb.com/webform

2. Select Begin DUNS search/request process

3. Select your country or territory and follow the instructions to obtain your

DUNS

9-digit #

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at

(http:// fedgov.dnb.com/ webform) or call 1-866-705-5711 http://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://www.sam.gov/portal/public/SAM/ http://grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://www.grants.gov/ http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under DUNS number 2 System for

Award Management (SAM) formerly Central Contractor Registration (CRR)

1. Retrieve organizations DUNS number

2. Go to www.sam.gov and designate an E-Biz POC (note CCR username will not not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact www.fsd.gov/US Calls: 866-606-8220

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to become an authorized organization representative (AOR)

2. Once the account is set up the

E-BIZ

POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization

Same day but can take 8 weeks to be fully registered and approved in the system (note, applicants

MUST obtain a

DUNS number and SAM account before applying on grants.gov)

Register early! Log into grants.gov and check AOR status until it shows you have been approved

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC PGO staff at 770-488-2700 or e-mail PGO PGOTIM@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.

4. Submission Dates and Times If the application is not submitted by the deadline published in the FOA, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline.

The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by OGS.

http://www.sam.gov/ http://www.fsd.gov/US http://www.grants.gov https://foa.grantsolutions.gov/announcementmodule/PGOTIM@cdc.gov%20

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: 01/29/2016

b. Application Deadline Due Date for Applications: 04/07/2016, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Date for Information Conference Call

Informational call will be held on Tuesday, February 2, 2016 at 2pm Eastern time.

Call in number: 855-644-0229 (Toll Free). Use passcode 6966716.

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent

A letter of intent (LOI) is requested but optional. The purpose of a letter of intent is to allow CDC program staff to estimate the number of and plan for the review of submitted applications.

Please include the following information in the LOI:

Descriptive title of proposed project;1.

Name, address, telephone number, and email address of the Principal Investigator or Project Director, or both;

2.

Name, address, telephone number, and e-mail address of the primary contact for writing and submitting this application; and

3.

Number and title of this FOA.4.

LOIs may be sent via email, U.S. express mail, or delivery service to:

Maggie Moore, MPH http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://www.grants.gov http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx

Maggie Moore, MPH

Public Health Advisor

CDC/NCCDPHP/DPH/AEWB/Epilepsy Program

RE: CDC-RFA-DP16-1602

4770 Buford Hwy, MS F-78

Atlanta, GA 30341 mmoore6@cdc.gov

8. Table of Contents (There is no page limit. The table of contents is not included in the project narrative page limit.): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary (Maximum 1 page) A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov.

The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

10. Project Narrative (Maximum of 20 pages, single spaced, 12 point font, 1-inch margins, number all pages. Content beyond 20 pages will not be reviewed. The 20 page limit includes the work plan.)

Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov. The Project Narrative must include all of the bolded headings shown in this section. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to be conducted over the entire project period as identified in the CDC Project Description section. Failure to follow the guidance and format may negatively impact scoring of the application.

a. Background Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose Applicants must describe in 2-3 sentences specifically how their application will address the public health problem as described in the CDC Background section.

ii. Outcomes Applicants must clearly identify the outcomes they expect to achieve by the end of the project period, as identified in the logic model in the Approach section of the CDC Project Description. Outcomes are the results that the program intends to achieve and usually indicate the intended direction of change (e.g., increase, decrease).

mailto:mmoore6@cdc.gov http://www.grants.gov

iii. Strategies and Activities Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the project period outcomes. Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan, how these strategies will be evaluated over the course of the project period. See the Strategies and Activities section of the CDC Project Description.

1. Collaborations Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC.

Applicants must include letters of support, MOUs, and/or MOAs demonstrating relationships with major partners, including from each affiliated program participating in this initiative. These letters will illustrate the applicant's capacity to work nationally and in a minimum of 25 states. Name the file “Letters of Support” or "MOU/MOAs", as appropriate, and upload it as a PDF file at www.grants.gov.

2. Target Populations Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. Refer back to the Target Population section in the CDC Project Description.

c. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this FOA. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement. The Paperwork Reduction Act of 1995 (PRA): Applicants are advised that any activities involving information collections (e.g., surveys, questionnaires, applications, audits, data requests, reporting, recordkeeping and disclosure requirements) from 10 or more individuals or non-Federal entities, including State and local governmental agencies, and funded or sponsored by the Federal Government are subject to review and approval by the Office of Management and Budget. See Section E (pages 4 and 5) at http://www.

hhs.gov/ asfr/ogapa/ aboutog/ogpoe/ gpd2-02.pdf. For further information about CDC’s requirements under PRA see http://www.hhs.gov/ ocio/policy/collection/.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant).

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan within the first 6 months of award, as described in the Reporting Section of this FOA.

Organizational capacity ensures that applicants demonstrate their ability to successfully execute the FOA http://www.grants.gov http://www.hhs.gov/asfr/ogapa/aboutog/ogpoe/gpd2-02.pdf http://www.hhs.gov/asfr/ogapa/aboutog/ogpoe/gpd2-02.pdf http://www.hhs.gov/ocio/policy/collection/

Organizational capacity ensures that applicants demonstrate their ability to…